fleroxacin has been researched along with Infections, Respiratory in 5 studies
Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fleroxacin, administered intravenously at a dosage of 400 mg once a day, was compared with ceftazidime, 0." | 6.67 | Intravenous fleroxacin versus ceftazidime in the treatment of acute nonpneumococcal lower respiratory tract infections. ( Farkas, SA, 1993) |
| " The once daily dosage of fleroxacin [400 mg once daily intravenously (i." | 2.68 | Quinolones in everyday clinical practice: respiratory tract infections and nosocomial pneumonia. ( Marklein, G, 1996) |
| " Both fleroxacin and lomefloxacin were given orally, the dosage was 200 mg every 12 hours or 400 mg every 24 hours for 7-14 days." | 2.68 | [A clinical study in the treatment of acute bacterial infections with fleroxacin]. ( Cui, H; Hou, J; Li, J, 1996) |
| "Fleroxacin, administered intravenously at a dosage of 400 mg once a day, was compared with ceftazidime, 0." | 2.67 | Intravenous fleroxacin versus ceftazidime in the treatment of acute nonpneumococcal lower respiratory tract infections. ( Farkas, SA, 1993) |
| "Fleroxacin is a new oral and intravenous trifluorinated 4-quinolone, which acts by inhibiting the essential bacterial enzyme DNA gyrase." | 2.39 | Fleroxacin overview. ( Naber, KG, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farkas, SA | 1 |
| Naber, KG | 1 |
| Marklein, G | 1 |
| Crokaert, F | 1 |
| Aoun, M | 1 |
| Duchateau, V | 1 |
| Grenier, P | 1 |
| Vandermies, A | 1 |
| Klastersky, J | 1 |
| Hou, J | 1 |
| Li, J | 1 |
| Cui, H | 1 |
1 review available for fleroxacin and Infections, Respiratory
| Article | Year |
|---|---|
Fleroxacin overview.
Topics: Animals; Anti-Infective Agents; Drug Interactions; Female; Fleroxacin; Humans; Respiratory Tract Inf | 1996 |
3 trials available for fleroxacin and Infections, Respiratory
| Article | Year |
|---|---|
Intravenous fleroxacin versus ceftazidime in the treatment of acute nonpneumococcal lower respiratory tract infections.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Bacteria; Bronchitis; Ceftazidime; Female; Fleroxacin | 1993 |
Quinolones in everyday clinical practice: respiratory tract infections and nosocomial pneumonia.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Double-Blind Method; Female; Fle | 1996 |
[A clinical study in the treatment of acute bacterial infections with fleroxacin].
Topics: Adult; Anti-Infective Agents; Female; Fleroxacin; Fluoroquinolones; Humans; Male; Middle Aged; Quino | 1996 |
1 other study available for fleroxacin and Infections, Respiratory
| Article | Year |
|---|---|
In vitro activity of trovafloxacin (CP-99,219), sparfloxacin, ciprofloxacin, and fleroxacin against respiratory pathogens.
Topics: Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Haemophilus influenzae; Humans; | 1996 |